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The persistence of common, heritable psychiatric disorders that reduce reproductive ﬁtness
is an evolutionary paradox. Here, we investigate the selection pressures on sequence
variants that predispose to schizophrenia, autism, bipolar disorder, major depression and
attention deﬁcit hyperactivity disorder (ADHD) using genomic data from 150,656 Icelanders,
excluding those diagnosed with these psychiatric diseases. Polygenic risk of autism and
ADHD is associated with number of children. Higher polygenic risk of autism is associated
with fewer children and older age at ﬁrst child whereas higher polygenic risk of ADHD is
associated with having more children. We ﬁnd no evidence for a selective advantage of a high
polygenic risk of schizophrenia or bipolar disorder. Rare copy-number variants conferring
moderate to high risk of psychiatric illness are associated with having fewer children and are
under stronger negative selection pressure than common sequence variants.
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P
sychiatric disorders present a paradox which has long
puzzled researchers. Mental illness usually begins in early
reproductive age and those affected have fewer children
than those unaffected by severe mental illness1,2. This, along
with the substantial heritability and prevalence of psychiatric
disorders, raises the question of why variants that increase the
risk of such diseases have not been purged from the gene pool3,4.
The reasons by which susceptibility alleles for mental
disorders persist in the population remain elusive, but three key
mechanisms have been proposed. Mutation-selection balance
postulates that selection against deleterious sequence variants is
balanced by the continuous occurrence of new mutations2,3,5.
Balancing selection suggests that variants that predispose to
psychiatric disorders may be beneﬁcial under some
circumstances, compensating for the deleterious effects
attributable to these disorders2,3,5. A third possibility is an
accumulation of common variants with effects on psychiatric
disorders that are individually too weak to be effectively targeted
by negative selection in most human populations6.
Rare recurrent copy-number variants (CNVs) with large effects
have been associated with schizophrenia, autism and bipolar
disorder in a subset of patients7,8. Two such CNVs have been
associated with decreased reproductive ﬁtness in carriers in the
general population, with male ﬁtness being particularly affected9.
The persistence of these CNVs in the gene pool is consistent with
mutation-selection balance. However, psychiatric disorders also
have a polygenic component, arising from the combined effect of
many common risk variants, each with small effect4. Polygenic
risk scoring is a method of summarizing an individual’s genetic
liability for a trait, by weighting alleles according to effect sizes
estimated in genome-wide association studies (GWAS)10. These
effects are summed together into a polygenic risk score (PRS),
that reﬂects the cumulative impact of many common variants on
a phenotype.
Association between PRS for psychiatric disorders and having
fewer children in undiagnosed individuals from the general
population would indicate that common risk variants are subject
to negative selection. Association between PRS and having more
children in individuals unaffected by psychiatric disorders would
support balancing selection. Lack of association between PRS and
number of children would indicate that there is either no
selection affecting these variants or weak selection pressure which
currently cannot be detected. Here, we test these hypotheses
using data from a sample of 150,656 Icelanders representing
approximately half of the population. CNVs implicated in autism
and schizophrenia are also tested for association with number of
children in carriers in the general population, to compare the
selection pressures on the common and rare components of the
genetic basis of psychiatric disorders. Finally, we determine
whether PRS for psychiatric disorders are associated with age at
ﬁrst child in the Icelandic population, to further dissect the link
between parental age and risk of psychiatric disorders11,12.
Our data show that polygenic risk for autism is associated with
fewer children and later age at ﬁrst child, while polygenic risk for
ADHD is associated with having more children. We ﬁnd no
evidence for a selective advantage of high polygenic risk for
schizophrenia or bipolar disorder. Rare CNVs conferring
moderate to high risk of psychiatric illness are associated with
having fewer children and are under stronger negative selection
pressure than common genetic variants.
Results
PRS and psychiatric disorders. PRS for ﬁve psychiatric disorders
were generated for each genotyped individual using the results of
independent GWAS on schizophrenia, bipolar disorder, autism,
attention deﬁcit hyperactivity disorder (ADHD) and major
depression, available online from the Psychiatric Genomics
Consortium (https://pgc.unc.edu/)13–17. We ﬁrst tested the
predictive power of each PRS for their corresponding disorder
within the Icelandic sample. All scores were signiﬁcantly
associated with their matching disorder (Fig. 1). The maximum
variance explained was 6.4% for schizophrenia
(P¼ 2.1 10 109). Other PRS explained up to 0.6% of the
variance for the corresponding diseases (Fig. 1).
PRS and number of children. We used a subset of 93,720
genotyped subjects, aged at least 45 years and without a diagnosis
of a psychiatric disorder, to test the association of each PRS with
the number of children born to each individual. There was a
negative association between the PRS for autism and number of
children (b¼  0.25, P¼ 0.002) (Table 1), while higher PRS for
ADHD was associated with having more children (b¼ 0.15,
P¼ 0.002) (Table 1). Other PRS were not associated with number
of children after Bonferroni correction for multiple tests (Table 1,
Supplementary Figs 1–5). The quadratic effects of the PRS were
also examined, to test whether very high or low PRS may be
associated with number of children, but these results were non-
signiﬁcant. Furthermore, there were no associations between
variance in number of children and deciles of PRS in the total
sample, males or females, after multiple testing correction
(Supplementary Figs 6–10).
Neuropsychiatric CNVs and number of children. In a subset of
patients with schizophrenia or autism, CNVs are likely to be the
strongest individual factors contributing to the pathogenesis of
the disorder. Eleven CNVs conferring risk of schizophrenia or
autism (‘neuropsychiatric CNVs’) were tested for association
with number of children, excluding individuals with autism,
schizophrenia, bipolar disorder and intellectual disability7,8.
Collectively, carriers of a neuropsychiatric CNV (N¼ 469) had
signiﬁcantly fewer children than non-carriers (N¼ 91,987)
(b¼  0.279, P¼ 0.0001), with a greater reduction in males
than females (Table 2). After correction for multiple comparisons,
the 16p11.2 deletion was individually associated with having
fewer children (Table 2).
Selection pressures on PRS versus neuropsychiatric CNVs.
Individuals in the top 1% of schizophrenia PRS have an odds
ratio of 9.5 (95% CI 6.8 13.3) of developing the disorder. While
this risk is of a magnitude similar to that conferred by a
single neuropsychiatric CNV, individuals with high PRS of
schizophrenia have the same number of children as the rest of the
population (b¼ 0.054, P¼ 0.29). However, they have a greater
variance in number of children (b¼ 1.112, P¼ 0.02). The same
comparison was performed for individuals in the top 1% of PRS
for autism and bipolar disorder. The difference in number of
children was not statistically signiﬁcant in the former
(b¼  0.085, P¼ 0.095, OR for autism¼ 2.4) while those in the
top 1% of bipolar disorder PRS were found to have fewer children
than the rest of the population (b¼  0.148, P¼ 0.0037, OR for
bipolar disorder¼ 1.6).
PRS and age at ﬁrst child. PRS for autism is associated with later
age at ﬁrst child in the total sample (b¼ 0.97, P¼ 0.0004)
(Table 3). PRS for ADHD is associated with younger age at ﬁrst
child for both sexes (b¼  0.59, P¼ 0.0003) and PRS for MDD
is associated with younger age at ﬁrst child in females
(b¼  0.56, P¼ 0.00009) (Table 3). Quadratic effects of PRS
were not found to be associated with age at ﬁrst child.
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Discussion
Here we have investigated selection pressures acting on sequence
variants conferring risk of psychiatric disorders in
recent generations of Icelanders by testing whether PRSs and
neuropsychiatric CNVs are associated with number of children in
a large population sample that excludes patients diagnosed with
the psychiatric diseases. PRS for autism was found to be
associated with having fewer children, indicating that common
variants that are thousands of years old are currently subject to
weak negative selection pressure.
Balancing selection as an explanation for the persistence of
these variants means that variants that increase the risk of
psychiatric disorders may persist if their negative effects on ﬁtness
in affected carriers are offset by beneﬁts in individuals who carry
the variants but do not develop the disorders3. PRS for
schizophrenia and bipolar disorder have been found to predict
creativity in the general population of Iceland18. However,
creative individuals in Iceland have fewer children than
population controls18. Based on these results, along with the
lack of association between these PRS and number of children
found here, we conclude that there is no evidence for a selective
advantage that maintains common variants associated with
schizophrenia or bipolar disorder. While greater PRS for
ADHD is associated with having more children in the Icelandic
population, we do not interpret this as support for balancing
selection. This is because individuals with ADHD have more
children than average in Iceland and in other populations19.
We recognize that a Bonferroni correction may be
over-conservative for this analysis, as one and the same variant
may predispose to several psychiatric disorders, meaning that the
PRS are not totally independent20,21. Furthermore, several of
these PRS currently only explain a small amount of variance in
risk of the disorders themselves (Fig. 1) and therefore may be
underpowered to detect associations with number of children,
even in this large population sample. As GWAS with greater
statistical power are conducted on psychiatric disorders and their
polygenic component can be estimated with greater accuracy,
other associations with reproductive ﬁtness may be uncovered.
One limitation of the current study is that selection pressures in
the modern environment may not be the same as those that acted
on our ancestors. For example, in recent times there have been
far-reaching cultural changes in factors such as education and the
use of contraception, which have led to a postponement of having
a ﬁrst child and a reduction in number of children in many
human populations. In our data, subjects diagnosed with
psychiatric disorders were excluded. However, some
unidentiﬁed patients in the sample could obscure evidence for
balancing selection.
Here, neuropsychiatric CNVs implicated in schizophrenia,
autism and bipolar disorder are associated with fewer children,
particularly among males. These CNVs are rare and generally
have large effects7,8. Several have been associated with lower IQ,
cognitive deﬁcits and other physical abnormalities, that may have
a negative impact on reproductive ﬁtness in population controls
Table 1 | Association between polygenic risk scores and number of children.
Total population Males FemalesPolygenic score
P value Beta (CI) P value Beta (CI) P value Beta (CI)
ADHD 0.002 0.15 (0.05, 0.25) 0.170 0.09 (0.04, 0.24) 0.002 0.20 (0.07, 0.33)
Autism 0.002 0.25 (0.41, 0.09) 0.003 0.36 (0.59, 0.12) 0.130 0.16 (0.38, 0.05)
Bipolar disorder 0.740 0.005 (0.03, 0.02) 0.500 0.01 (0.02, 0.05) 0.310 0.02 (0.05, 0.01)
Major depression 0.170 0.04 (0.01, 0.11) 0.650 0.02 (0.07, 0.12) 0.094 0.07 (0.01, 0.16)
Schizophrenia 0.160 0.006 (0.002, 0.01) 0.530 0.004 (0.008, 0.02) 0.170 0.007 (0.003, 0.02)
In total, ten tests on number of children were performed; thus the signiﬁcance threshold is Po0.005.
CI—95% conﬁdence interval
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Figure 1 | Polygenic risk scores for psychiatric disorders predict their corresponding disorder in the general population of Iceland. The x axis shows the
seven P-value parameters (0.001, 0.003, 0.01, 0.03, 0.1, 0.3 and 1.0) used to weight SNPs from the discovery GWAS plotted left to right. The y axis
indicates the Nagelkerke’s pseudo-R2 measure of variance explained.
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who have not been diagnosed with psychotic or
neurodevelopmental disorders9,22. De novo CNVs have been
implicated in cases of schizophrenia, autism and bipolar disorder
which supports mutation-selection balance. A previous study
has also shown that there is a strong selection against
schizophrenia-associated CNVs, such that these variants persist
in the population for only a few generations after they arise23.
Finally, age at ﬁrst child is of particular interest as Western
society has experienced a rapid postponement of parenthood24,
which has been associated with reduction in polygenic score for
educational attainment25. Delayed fatherhood has been linked to
risk of psychiatric disorders, widely assumed to be caused by the
accumulation of de novo mutations in the spermatogonial stem
cells of older males26,27. However, recent population genetic
modelling suggests that these mutations are unlikely to explain
much of the risk and a weak correlation between age at ﬁrst child
and genetic liability to psychiatric illness could account for the
observed incidence of the disorders in the children of older
fathers11. In accordance with this hypothesis, PRS for autism was
positively associated with later age at ﬁrst child in the Icelandic
population, providing an alternative explanation of age-related
mutations.
In summary, our results show that common sequence variants
conferring risk of autism and ADHD are currently under weak
selection in the general population of Iceland. However, rare
CNVs that also impact cognition are under stronger selection
pressure, consistent with mutation-selection balance. The
hypothesis that a selective advantage accounts for the prevalence
of sequence variants conferring risk of schizophrenia and bipolar
disorder is unproven, but rather this empirical evidence suggests
that common sequence variants largely escape selection as their
individual effect sizes are weak.
Methods
Subjects. The study was approved by the National Bioethics Committee of
Iceland and the Icelandic Data Protection Authority. Samples are from a
population genetic biobank of 150,656 Icelanders established by deCODE genetics.
Reproductive ﬁtness was deﬁned as the number of children born to individuals
over 45 years. Subjects born before 1968 with matching genotypic data
(N¼ 93,720) were identiﬁed from deCODE’s nation-wide genealogy database.
This contains information on year of birth, county of birth and numbers of
children of Icelanders. Diagnoses of schizophrenia and bipolar disorder were
assigned according to Research Diagnostic Criteria (RDC)28 through the use of the
Schedule for Affective Disorders and Schizophrenia Lifetime Version (SADS-L)29.
ADHD subjects were recruited from outpatient pediatric, child and adult
psychiatry clinics in Iceland; ICD-10 diagnoses were made on the basis of
standardized diagnostic assessments by experienced clinicians. Autism subjects
were ascertained through the State Diagnostic Counseling Center and the
Department of Child and Adolescent Psychiatry in Iceland and received ICD-10
diagnoses based on standardized diagnostic assessments by clinical specialists.
Diagnoses of MDD were made by clinicians or based on the results of a
semi-structured interview (CIDI), and were assigned according to DSM-III, ICD-9
or ICD-10 criteria. All diagnoses of recurrent depression were included (that is,
mild, moderate and severe), but in the case of single episode depression mild cases
were excluded. Characteristics of the sample are shown in Supplementary Table 1.
Genotyping and imputation. Genotyping was performed on Illumina HumanHap
(300, 370, 610, 1 M, 2.5 M) and IlluminaOmni (670, 1 M, 2.5 M, Express) SNP
arrays9. BeadStudio (Illumina; version 2.0) was used to call genotypes, normalize
signal intensity data and establish the log R ratio and B allele frequency at every
SNP. Long-range haplotype phasing was achieved using an iterative algorithm,
which phases a single proband at a time, given the available phasing information
on all other individuals who share a long haplotype identically by state with the
Table 2 | Association between neuropsychiatric CNVs and number of children.
CNV Odds ratio
(autism/schizophrenia)
Carriers
(male/female)
Non-carriers
(male/female)
Beta
(male/female)
P value
(male/female)
All CNVs 201/268 42,826/49,161 0.405/0.184 0.00028/0.050
Autism CNVs 37/60 42,990/49,369  1.263/0.481 9.4E07/0.014
Schizophrenia CNVs 189/256 42,838/49,173 0.266/0.115 0.021/0.23
16p11.2 del inf/NA 12/12 43,015/49,417  2.534/ 1.59 1.8E08/0.00025
1q21.1 del NA/8.35 11/15 43,016/49,414 0.741/0.98 0.12/0.012
22q11.21 del NA/inf 3 92,453  1.421 0.11
16p11.2 dup 4.1/11.52 39 92,417 0.326 0.19
15q11.2—13.1 dup inf/13.20 4 92,452 0.926 0.23
7q11.23 (WBS) dup NA/11.35 3 92,453  1.150 0.23
15q13.3 all del inf/7.52 19 92,437 0.343 0.34
16p13.1 dup NA/2.30 103 92,353 0.128 0.41
2p16.1 (NRXN1) del 5.6/9.01 11 92,445 0.353 0.45
15q11.2 all del NA/2.15 192 92,264 0.058 0.61
1q21.1 dup NA/3.45 38 92,418 0.049 0.85
Results are shown in males and females separately when there is a signiﬁcant (Po0.05) association in either group. Counting all models ﬁtted, 28 tests were performed; thus the signiﬁcance threshold is
Po0.0017. Odds ratios for autism and schizophrenia are from the literature7,8.
Table 3 | Association between polygenic risk scores and age at ﬁrst child.
Total sample Males FemalesPolygenic score
P value Beta (CI) P value Beta (CI) P value Beta (CI)
ADHD 0.0003 0.59 (0.92, 0.26) 0.07 0.48 (0.99, 0.03) 0.0005 0.71 ( 1.12, 0.31)
Autism 0.0004 0.97 (0.43, 1.51) 0.03 0.91 (0.08, 1.76) 0.001 1.10 (0.45, 1.77)
Bipolar disorder 0.005 0.14 (0.04, 0.23) 0.18 0.10 (0.04, 0.25) 0.007 0.16 (0.04  0.28)
Major depression 0.006 0.31 (0.54, 0.09) 0.71 0.06 (0.42, 0.28) 9.00E05 0.56 (0.84, 0.28)
Schizophrenia 0.07 0.02 (0.05, 0.003) 0.81 0.005 (0.05, 0.04) 0.02 0.04 (0.07, 0.01)
In total, ten tests on age at ﬁrst child were performed; thus the signiﬁcance threshold is Po0.005.
CI—95% conﬁdence interval
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proband30. Given the large proportion of the Icelandic population that has been
chip-typed, accurate genome-wide long-range phasing is possible for all chip-typed
Icelanders. For long-range phased haplotype association analysis, the genome was
then partitioned into non-overlapping ﬁxed 0.3 cm bins. Within each bin, the
haplotype diversity was consistent with the combination of all chip-typed markers
in the bin. The whole genomes of 8,453 Icelanders were sequenced using Illumina
technology to a mean depth of at least  10 (median  32). SNPs and indels were
identiﬁed and genotypes called using join calling with the Genome Analysis
Toolkit Haplotype Caller (GATK version 3.3.0) (ref. 31). The error rate of genotype
calls made solely on the basis of next generation sequence data decreases as a
function of sequencing depth. Taking advantage of the fact that all the sequenced
individuals had also been chip-typed and long-range phased, information about
haplotype sharing was utilized to minimize the number of such errors.
Thus, the genotype call in cases where sequence reads were ambiguous would be
informed by comparison with sequence reads of other individuals sharing
haplotypes with the individual in question at the ambiguous site. To improve
genotype quality and to phase the sequencing genotypes an iterative algorithm
based on the IMPUTE HMM model32 and using the long range phased haplotypes
was employed33. The same principle was then used to impute the sequence variants
identiﬁed in the 8,453 sequenced Icelanders into 150,656 Icelanders who had been
genotyped with various Illumina SNP arrays and their genotypes phased using
long-range phasing33.
Polygenic risk scoring and CNV selection. We derived PRSs from GWAS
summary results available online from the Psychiatric Genomics Consortium
(https://pgc.unc.edu/) for ADHD, autism, bipolar disorder, major depression and
schizophrenia13–17. The number of cases in these studies was 896, 3,303, 7,481,
9,240 and 35,476 respectively. The deCODE sample was not part of these analyses.
To compute the PRSs we used approximately 630,000 autosomal markers from a
framework set of markers used in long-range haplotype phasing. The
framework markers have been selected on the basis of various quality criteria
including high genotype yield, Hardy–Weinberg equilibrium and consistency of
allele frequencies across different Illumina array types. We estimated the linkage
disequilibrium between markers using Icelandic samples and adjusted for it using
LDpred34 a recently proposed method. PRSs were calculated with seven different
settings of the P parameter (corresponding roughly to the fraction of causal
markers34): 0.001, 0.003, 0.01, 0.03, 0.1, 0.3 and 1.0. Eleven CNVs conferring risk of
schizophrenia or autism (‘neuropsychiatric CNVs’) were selected from the most
recent review on CNVs in schizophrenia7 and the most recent analysis of CNVs in
autism8.
Statistical analysis. PRSs were ﬁrst tested for association with their corre-
sponding psychiatric disorder in the Icelandic population (N¼ 1,137, 692, 806,
3,246 and 631 cases for ADHD, autism, bipolar disorder, major depression and
schizophrenia respectively). This was performed using logistic regression with ﬁve
principal components as covariates. Models were compared against a null model
including covariates only to calculate the Nagelkerke’s pseudo-R2 measure of
variance explained. A linear mixed effects model was used to test the association of
number of children with PRS for the ﬁve psychiatric disorders. Number of children
was regressed on the PRS of interest, covarying for year of birth, sex and interaction
between the two, birth county of last child or birth county of the parent, ﬁve
principal components and sibship (to account for relatedness). For each respective
disorder we chose the PRS calculated with a P parameter corresponding to a
fraction of causal markers of 0.3 and modelled the correlation with its respective
disorder and then recalibrated the PRS to have a mean of 0 and a unit increase
corresponding to a doubling of risk for the disorder. All predictors were modelled
as ﬁxed effects apart from sibship which was random. This model was compared
against a null model including the covariates only. To test the quadratic effects of
the PRS, a PRS squared term was added and PRS was included in the null model.
Sex-speciﬁc analyses were also conducted. Individuals diagnosed with each
psychiatric disorder were excluded, although it may not be possible to identify
every past case in a general population sample. Age at ﬁrst child was tested for
association with each PRS in the same manner. To examine the relationship
between variance in number of children and PRSs, PRSs were split into deciles and
number of children was adjusted for all covariates. A linear regression was used to
test the association between deciles of PRS and residual number of children in the
total sample, males and females. Neuropsychiatric CNVs were examined for
association with number of children using the following covariates: year of birth,
sex and interaction between the two, birth county of last child or birth county of
the parent, ﬁve principal components and the random effect of sibship. Individuals
with autism, schizophrenia, bipolar disorder and intellectual disability were
excluded from the CNV analyses.
Data availability. Data supporting the ﬁndings of this study are available within
the article and its Supplementary Information ﬁles. Summary level data from the
PGC GWAS used to calculate PRS in this study were obtained from the PGC
Downloads website (https://www.med.unc.edu/pgc/results-and-downloads/).
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